NCT00370266

Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: Shahid Beheshti University of Medical Sciences · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether intraocular injection of triamcinolone is effective in the treatment of macular edema in acute branch retinal vein occlusion.

Detailed description

Intravitreal triamcinolone has recently been shown to have beneficial effect on chronic macular edema due to vein occlusion and preventive effect on neovascularization. Hypothetically, prevention of macular derangement by reducing the amount of edema from early phase after occlusion until restoration of collaterals seems to be helpful in these eyes. To our knowledge, no prospective randomized clinical trial, considering both macular changes and preventive effect on neovascularization has been published for intravitreal triamcinolone in acute branch retinal vein occlusion.

Conditions

• Branch Retinal Vein Occlusion

Interventions

Type	Name	Description
DRUG	Triamcinolone

Timeline

• Start date: 2003-02-01
• Primary completion: 2007-10-01
• Completion: 2007-12-01
• First posted: 2006-08-31
• Last updated: 2008-06-17

Locations

1 site across 1 country: Iran